{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T17:28:02Z","timestamp":1770571682697,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.clinthera.2006.05.004","type":"journal-article","created":{"date-parts":[[2006,7,25]],"date-time":"2006-07-25T11:57:04Z","timestamp":1153828624000},"page":"734-744","source":"Crossref","is-referenced-by-count":91,"title":["Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects"],"prefix":"10.1016","volume":"28","author":[{"given":"Steven","family":"Ramael","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"De Smedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Toublanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Otoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Boulanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Riethuisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armel","family":"Stockis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2006.05.004_bib1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2165\/00023210-200216090-00001","article-title":"Potential new methods for antiepileptic drug delivery","volume":"16","author":"Fisher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.clinthera.2006.05.004_bib2","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/WNL.51.5.1274","article-title":"Treating repetitive seizures with a rectal diazepam formulation: A randomized study","volume":"51","author":"Cereghino","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2006.05.004_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/088307380201700206","article-title":"Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: Prospective randomized study","volume":"17","author":"Fisgin","year":"2002","journal-title":"J Child Neural"},{"key":"10.1016\/j.clinthera.2006.05.004_bib4","first-page":"469","article-title":"Management of status epilepticus","volume":"68","author":"Sirven","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clinthera.2006.05.004_bib5","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000 mg\/d in patients with refractory partial seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2006.05.004_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.55.2.236","article-title":"Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial","volume":"55","author":"Cereghino","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2006.05.004_bib7","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1528-1157.2000.tb00323.x","article-title":"Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures","volume":"41","author":"Shorvon","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2006.05.004_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0920-1211(03)00080-9","article-title":"The KEEPER trial: Levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study","volume":"54","author":"Morrell","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.clinthera.2006.05.004_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","article-title":"Clinical pharmacokinetics of levetiracetam","volume":"43","author":"Patsalos","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2006.05.004_bib10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1183\/09031936.95.08091445","article-title":"More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited","volume":"8","author":"Naeije","year":"1995","journal-title":"Eur Respir J."},{"key":"10.1016\/j.clinthera.2006.05.004_bib11","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1023\/A:1007669411738","article-title":"Bioanalytical method validation\u2014a revisit with a decade of progress","volume":"17","author":"Shah","year":"2000","journal-title":"Pharm Res."},{"key":"10.1016\/j.clinthera.2006.05.004_bib12","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1177\/0091270003258173","article-title":"Levetiracetam: Relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets","volume":"43","author":"Coupez","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2006.05.004_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1528-1157.2003.25302.x","article-title":"Levetiracetam, a new antiepileptic agent: Lack of in vitro and in vivo pharmacokinetic interaction with valproic acid","volume":"44","author":"Coupez","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2006.05.004_bib14","series-title":"Parameters for Compartment-Free Pharmacokinetics. Standardisation of Study Design, Data Analysis and Reporting","year":"1999"},{"key":"10.1016\/j.clinthera.2006.05.004_bib15","series-title":"Design and Analysis of Goss-over Trials","author":"Jones","year":"1989"},{"key":"10.1016\/j.clinthera.2006.05.004_bib16","first-page":"105","article-title":"Update on the statistical analysis of bioequivalence studies","volume":"28","author":"Steinijans","year":"1990","journal-title":"Intj Gar Pharmacol Ther Toxicol"},{"key":"10.1016\/j.clinthera.2006.05.004_bib17","series-title":"Design and Analysis of Bioavailability and Bioequivalence Studies","author":"Chow","year":"1998"},{"key":"10.1016\/j.clinthera.2006.05.004_bib18","first-page":"1","article-title":"Sample size determination for bioequivalence assessment by means of confidence intervals","volume":"29","author":"Diletti","year":"1991","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.clinthera.2006.05.004_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0920-1211(02)00250-4","article-title":"Effects of antiepileptic comedication on levetiracetam pharmacokinetics: A pooled analysis of data from randomized adjunctive therapy trials","volume":"53","author":"Perucca","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.clinthera.2006.05.004_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2005.01.005","article-title":"Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: A pooled analysis of data from randomized clinical trials","volume":"64","author":"Gidal","year":"2005","journal-title":"Epilepsy Res."},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2006.05.004_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1528-1157.2001.00008.x","article-title":"Safety profile of levetiracetam","volume":"42","author":"Harden","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2006.05.004_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","article-title":"Pharmacokinetic profile of levetiracetam: Toward ideal characteristics","volume":"85","author":"Patsalos","year":"2000","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2006.05.004_bib23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00228-003-0655-6","article-title":"Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers","volume":"59","author":"Strolin Benedetti","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2006.05.004_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0920-1211(01)00296-0","article-title":"A systematic review of the safety profile of levetiracetam: Anew antiepileptic drug","volume":"47","author":"French","year":"2001","journal-title":"Epilepsy Res."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806001159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806001159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T06:10:22Z","timestamp":1683526222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291806001159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0149291806001159"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2006.05.004","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}